Auxilium

Auxilium is an innovation studio and accelerator based in Worcester, Massachusetts. Founded in June 2025, it focuses on supporting early-stage startups through various programs that offer essential resources and mentorship.

Auxilium invests in early-stage startups through its Innovation Studio and Accelerator programs. The Innovation Studio provides workshops, resources, strategic mentorship, and milestone-based investments of up to $100,000. The Accelerator program targets scalable startups with an initial investment of $250,000, along with workspace and tailored support.

Auxilium offers workspace, training, resources, mentorship, and funding to early-stage startups, helping them navigate their entrepreneurial journey.

<p><strong>What are the eligibility criteria for Auxilium?</strong></p><p>Auxilium seeks early-stage startups in the healthcare and biotech sectors, particularly those at the pre-seed, seed, and seed-plus stages.</p><p><strong>How does the application process work?</strong></p><p>Founders can apply through the Auxilium website. The application is currently open, and interested startups should prepare a detailed business plan and pitch.</p><p><strong>What are the deal terms for accepted startups?</strong></p><p>Auxilium offers an initial investment of $250,000 for the Accelerator program and up to $100,000 in milestone-based funding for the Innovation Studio.</p><p><strong>What is the format of the program?</strong></p><p>The program includes mentorship, workspace, and resources tailored to the needs of early-stage startups. Specific details about the duration and structure are not provided.</p><p><strong>What makes Auxilium different from other accelerators?</strong></p><p>Auxilium focuses specifically on healthcare and biotech startups, providing tailored support and significant funding to help founders achieve their milestones.</p><p><strong>What are the success metrics for Auxilium?</strong></p><p>Success metrics include the progress of startups through milestone achievements, funding raised, and the overall impact on the healthcare and biotech sectors.</p>